Philips ceases sales of sleep apnoea devices following FDA deal
Though Philips set aside €363m in Q4 2023 to deal with the long-running issues, the company remains confident of future revenue targets.
30 January 2024
30 January 2024
Though Philips set aside €363m in Q4 2023 to deal with the long-running issues, the company remains confident of future revenue targets.
The company received approval for new options in its Mini-Frag System, including additional screw and plate options.
The study uses multispectral optoacoustic tomography (MSOT) imaging and a unique contrast agent to detect pancreatic cancer cells with precision.
The ENDPOINT web application allows engineers to test orthopedic screw designs using advanced computational modeling.
Exablate Prime is designed to offer improved precision and efficiency in neurosurgery.
The spinal implant system can be used in vertebral compression fracture repair, a market forecast to generate $149m in the US by 2030.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.